Contemplate the data and tweets to guess whether the closing price of $bmy will surge or decline at 2017-04-05. Please declare either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-22,-1.2,0.1,-2.1,1.2,1.2,0.1,1.1,1.0,0.9,0.1,-1.1
2017-03-23,0.6,1.4,-0.2,-1.0,-1.0,0.6,1.7,2.0,1.9,1.2,0.1
2017-03-24,-0.0,0.6,-0.4,0.2,0.2,0.2,1.1,1.6,1.7,1.1,0.2
2017-03-27,-0.8,0.6,-0.9,0.3,0.3,-0.2,0.7,1.2,1.3,1.0,0.2
2017-03-28,-0.3,0.3,-0.5,0.3,0.3,-0.3,0.3,0.9,1.0,0.8,0.1
2017-03-29,0.4,1.1,-0.0,-0.4,-0.4,0.0,0.4,1.2,1.3,1.3,0.7
2017-03-30,1.1,1.2,-0.2,-1.1,-1.1,1.0,1.2,2.0,2.3,2.3,1.8
2017-03-31,1.7,2.4,-0.4,-1.8,-1.8,2.2,2.6,3.3,3.9,4.0,3.7
2017-04-03,0.6,1.8,-0.6,-0.3,-0.3,1.9,2.5,3.3,3.9,4.2,4.0
2017-04-04,0.1,0.4,-0.4,-0.1,-0.1,1.2,2.4,3.1,3.9,4.1,4.1

2017-03-22: AT_USER what's  all this have to do with $bmy?|the svp &amp; controller of bristol myers (nyse: bmy) is selling shares $bmy |bristol-myers squibb company's svp &amp; controller just disposed of 8,096 
2017-03-23: rt AT_USER bristol failure makes small dent in cxcr4-blocking approach   $bmy|could nektar therapeutics be worth more? AT_USER #stocks $shpg, $bmy, $azn, $nktr, $bayry |bristol failure makes small den
2017-03-24: rt AT_USER $bmy: #opdivo receives positive chmp opinion for squamous head and neck #cancer following platinum-based therapy:|$bmy is in ema33 breakout winning 67.14% in the past. | members have an adv
2017-03-25: $pfe, merck kgaa fourth to market with pd-1/l1 inhibitor  $bmy $rhhby $mrk|$bmy get 14 days #free #premium access on the #1 #stock #app &amp; #trump competition:  #nyctaf #ultra2017|$bmy get 14 days #
2017-03-26: rt AT_USER top 10 overbought names in $spy: $noc $rop $has $amg $aapl $agn $rht $prgo $bmy $ctxs |bristol-myers squibb co $bmy downgraded by vetr inc. to ¡°hold¡± |bristol-myers squibb co $bmy downgra
2017-03-27: $bmy is in three inside up winning 63.64% in the past. |rt AT_USER credit suisse analysis shows value in hypothetical pfizer-bristol merger $pfe $bmy $nvs $gild |rt AT_USER credit suisse analysis show
2017-03-28: rt AT_USER benzinga's option alert recap from march 28  $afsi $alrm $amat $spls $mycc $bmy $kite $casy $res $five|$bmy is in scoop pattern winning 85.71% in the past. |benzinga: benzinga's option aler
2017-03-29: bristol-myers squibb co $bmy director lamberto andreotti sells 34,000 shares |bristol-myers squibb co $bmy director lamberto andreotti sells 34,000 shares |bristol-myers squibb co $bmy director lamber
2017-03-30: #bristolmyerssquibb bristol-myers squibb co director lamberto andreotti sells 34,000 shares. read more:  $bmy|#bristolmyerssquibb bristol-myers squibb co director lamberto andreotti sells 34,000 share
2017-03-31: our $bmy smarttrack found : AT_USER carnivalesque by neil jordan is now available for pre-order!     #markets | members have an advantage. see track record &amp; join  $bmy $pot $apa $cnq $ccl $ba|#br
2017-04-01: rt AT_USER  alerted another winner. must see track record &amp; subscribe  $jah $clr $d¡­|rt AT_USER $bmy before the weekend. selling put 50 for may. seems abit over sold and ~47 is support. high prob
2017-04-02: stocks going ex-dividend the first week of april  $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $gps $intu $jpm|stocks going ex-dividend the first week of april $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $
2017-04-03: rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 |earlybird twitter approved for trade floors. $bmy gay talese, author of high notes, was interviewed o
2017-04-04: rt AT_USER AT_USER adam please look into $bmy collaboration with AT_USER and $nwbo trial starts 4/17 |$bmy bmo capital reiterates market perform rating, $45 pt |bristol-myers squibb co $bmy rating rei
Answer:
Contemplate the data and tweets to guess whether the closing price of $bmy will surge or decline at 2017-04-05. Please declare either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-22,-1.2,0.1,-2.1,1.2,1.2,0.1,1.1,1.0,0.9,0.1,-1.1
2017-03-23,0.6,1.4,-0.2,-1.0,-1.0,0.6,1.7,2.0,1.9,1.2,0.1
2017-03-24,-0.0,0.6,-0.4,0.2,0.2,0.2,1.1,1.6,1.7,1.1,0.2
2017-03-27,-0.8,0.6,-0.9,0.3,0.3,-0.2,0.7,1.2,1.3,1.0,0.2
2017-03-28,-0.3,0.3,-0.5,0.3,0.3,-0.3,0.3,0.9,1.0,0.8,0.1
2017-03-29,0.4,1.1,-0.0,-0.4,-0.4,0.0,0.4,1.2,1.3,1.3,0.7
2017-03-30,1.1,1.2,-0.2,-1.1,-1.1,1.0,1.2,2.0,2.3,2.3,1.8
2017-03-31,1.7,2.4,-0.4,-1.8,-1.8,2.2,2.6,3.3,3.9,4.0,3.7
2017-04-03,0.6,1.8,-0.6,-0.3,-0.3,1.9,2.5,3.3,3.9,4.2,4.0
2017-04-04,0.1,0.4,-0.4,-0.1,-0.1,1.2,2.4,3.1,3.9,4.1,4.1

2017-03-22: AT_USER what's  all this have to do with $bmy?|the svp &amp; controller of bristol myers (nyse: bmy) is selling shares $bmy |bristol-myers squibb company's svp &amp; controller just disposed of 8,096 
2017-03-23: rt AT_USER bristol failure makes small dent in cxcr4-blocking approach   $bmy|could nektar therapeutics be worth more? AT_USER #stocks $shpg, $bmy, $azn, $nktr, $bayry |bristol failure makes small den
2017-03-24: rt AT_USER $bmy: #opdivo receives positive chmp opinion for squamous head and neck #cancer following platinum-based therapy:|$bmy is in ema33 breakout winning 67.14% in the past. | members have an adv
2017-03-25: $pfe, merck kgaa fourth to market with pd-1/l1 inhibitor  $bmy $rhhby $mrk|$bmy get 14 days #free #premium access on the #1 #stock #app &amp; #trump competition:  #nyctaf #ultra2017|$bmy get 14 days #
2017-03-26: rt AT_USER top 10 overbought names in $spy: $noc $rop $has $amg $aapl $agn $rht $prgo $bmy $ctxs |bristol-myers squibb co $bmy downgraded by vetr inc. to ¡°hold¡± |bristol-myers squibb co $bmy downgra
2017-03-27: $bmy is in three inside up winning 63.64% in the past. |rt AT_USER credit suisse analysis shows value in hypothetical pfizer-bristol merger $pfe $bmy $nvs $gild |rt AT_USER credit suisse analysis show
2017-03-28: rt AT_USER benzinga's option alert recap from march 28  $afsi $alrm $amat $spls $mycc $bmy $kite $casy $res $five|$bmy is in scoop pattern winning 85.71% in the past. |benzinga: benzinga's option aler
2017-03-29: bristol-myers squibb co $bmy director lamberto andreotti sells 34,000 shares |bristol-myers squibb co $bmy director lamberto andreotti sells 34,000 shares |bristol-myers squibb co $bmy director lamber
2017-03-30: #bristolmyerssquibb bristol-myers squibb co director lamberto andreotti sells 34,000 shares. read more:  $bmy|#bristolmyerssquibb bristol-myers squibb co director lamberto andreotti sells 34,000 share
2017-03-31: our $bmy smarttrack found : AT_USER carnivalesque by neil jordan is now available for pre-order!     #markets | members have an advantage. see track record &amp; join  $bmy $pot $apa $cnq $ccl $ba|#br
2017-04-01: rt AT_USER  alerted another winner. must see track record &amp; subscribe  $jah $clr $d¡­|rt AT_USER $bmy before the weekend. selling put 50 for may. seems abit over sold and ~47 is support. high prob
2017-04-02: stocks going ex-dividend the first week of april  $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $gps $intu $jpm|stocks going ex-dividend the first week of april $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $
2017-04-03: rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 |earlybird twitter approved for trade floors. $bmy gay talese, author of high notes, was interviewed o
2017-04-04: rt AT_USER AT_USER adam please look into $bmy collaboration with AT_USER and $nwbo trial starts 4/17 |$bmy bmo capital reiterates market perform rating, $45 pt |bristol-myers squibb co $bmy rating rei
Answer:+Fall